Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Myostatin mutations boost muscle mass in mice; leaves open whether blockade benefits human muscle-wasting disorders.
John Spizizen (1957) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: